Science Explorer Back to mapMap

Most cited papers from Translational Therapeutics (United States)

Translational Therapeutics (United States)

What are the most cited papers from Translational Therapeutics (United States)?

The most cited paper from Translational Therapeutics (United States) is "Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)" (Daniel J. Klionsky et al., 2016), with 6,023 citations. Next come "Prostaglandins and Inflammation" (3,833) and "Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology" (3,829).

Showing 50 of 60 papers. Every paper with more than 607 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors 2 Jan 2016 6,023
2 Prostaglandins and Inflammation Emanuela Ricciotti, Garret A. FitzGerald · Arteriosclerosis Thrombosis and Vascular Biology Open access 20 Apr 2011 3,833
3 Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology Colin D. Funk · Science 30 Nov 2001 3,829
4 Biological, clinical and population relevance of 95 loci for blood lipids Tanya M. Teslovich et al. · Nature Open access209 authors Aug 2010 3,706
5 Oncogenic Signaling Pathways in The Cancer Genome Atlas Francisco Sánchez-Vega et al. · Cell Open access779 authors Apr 2018 3,452
6 Discovery and refinement of loci associated with lipid levels Cristen J. Willer et al. · Nature Genetics Open access259 authors 6 Oct 2013 3,319
7 The Human Cell Atlas Aviv Regev et al. · eLife Open access 5 Dec 2017 2,441
8 Opportunities and obstacles for deep learning in biology and medicine Travers H. Ching et al. · Journal of The Royal Society Interface Open access Apr 2018 2,322
9 CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer Laura M. McLane, Mohamed S. Abdel-Hakeem, E. John Wherry · Annual Review of Immunology Review 24 Jan 2019 2,076
10 Complement and its role in innate and adaptive immune responses Jason Dunkelberger, Wen‐Chao Song · Cell Research 15 Dec 2009 1,994
11 Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis Amit Khera, Marina Cuchel, Margarita de la Llera-Moya et al. · New England Journal of Medicine Open access 12 Jan 2011 1,968
12 Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Cardiogenics et al. · Nature Genetics Open access167 authors 6 Mar 2011 1,959
13 TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion Omar Khan et al. · Nature Open access 17 Jun 2019 1,705
14 Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications Divij Mathew et al. · Science Open access 15 Jul 2020 1,667
15 The Missing Diversity in Human Genetic Studies Giorgio Sirugo, Scott M. Williams, Sarah A. Tishkoff · Cell Open access Mar 2019 1,625
16 Human chimeric antigen receptor macrophages for cancer immunotherapy Michael Klichinsky et al. · Nature Biotechnology Open access 23 Mar 2020 1,493
17 Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities Zhiliang Cheng, Ajlan Al Zaki, James Z. Hui et al. · Science Open access 15 Nov 2012 1,327
18 Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments Alessia Angelin, Luis Gil‐de‐Gómez, Satinder Dahiya et al. · Cell Metabolism Open access 13 Apr 2017 1,251
19 Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Theo Knijnenburg et al. · Cell Reports Open access763 authors Apr 2018 1,249
20 Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells Omkar Uday Kawalekar, Roddy S. O’Connor, Joseph A. Fraietta et al. · Immunity Open access Feb 2016 1,247
21 From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus Kiran Musunuru et al. · Nature Open access Aug 2010 1,204
22 JTK_CYCLE: An Efficient Nonparametric Algorithm for Detecting Rhythmic Components in Genome-Scale Data Sets Michael E. Hughes, John B. Hogenesch, Karl Kornacker · Journal of Biological Rhythms Open access 28 Sep 2010 1,198
23 The value of antimicrobial peptides in the age of resistance Maria Magana, Pushpanathan Muthuirulan, Ana L. Santos et al. · The Lancet Infectious Diseases 9 Jul 2020 1,169
24 Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms Jean‐Christophe Beltra, Sasikanth Manne, Mohamed S. Abdel-Hakeem et al. · Immunity Open access May 2020 1,135
25 The genetic architecture of type 2 diabetes Christian Fuchsberger et al. · Nature Open access301 authors 11 Jul 2016 1,129
26 Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis Trista E. North, Wolfram Goessling, Carl R. Walkley et al. · Nature Open access Jun 2007 1,110
27 Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Sekar Kathiresan et al. · Nature Genetics Open access123 authors 8 Feb 2009 1,106
28 NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR Jun Yoshino, Joseph A. Baur, Shin‐ichiro Imai · Cell Metabolism Open access 14 Dec 2017 1,086
29 Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society M. Cuchel et al. · European Heart Journal Open access 22 Jul 2014 1,078
30 Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities Tilo Großer · Journal of Clinical Investigation Open access 8 Dec 2005 1,026
31 Protein kinase C and other diacylglycerol effectors in cancer Erin Griner, Marcelo G. Kazanietz · Nature reviews. Cancer Review 23 Mar 2007 978
32 Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the Genome Abdenour Soufi, Greg Donahue, Kenneth S. Zaret · Cell Open access Nov 2012 962
33 Decade-long leukaemia remissions with persistence of CD4+ CAR T cells Jan Joseph Melenhorst et al. · Nature Open access 2 Feb 2022 952
34 mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern Rishi R. Goel et al. · Science Open access 14 Oct 2021 952
35 Understanding multicellular function and disease with human tissue-specific networks Casey S. Greene, Arjun Krishnan, Aaron K. Wong et al. · Nature Genetics Open access 27 Apr 2015 946
36 Common variants associated with plasma triglycerides and risk for coronary artery disease Ron Do et al. · Nature Genetics Open access263 authors 6 Oct 2013 912
37 Coxibs and Cardiovascular Disease Garret A. FitzGerald · New England Journal of Medicine 6 Oct 2004 901
38 HDL and cardiovascular disease Daniel James Rader, G. Kees Hovingh · The Lancet Aug 2014 888
39 T cell responses in patients with COVID-19 Zeyu Chen, E. John Wherry · Nature reviews. Immunology ReviewOpen access 29 Jul 2020 882
40 Pioneer Transcription Factors Target Partial DNA Motifs on Nucleosomes to Initiate Reprogramming Abdenour Soufi, Meilín Fernández García, Artur Jaroszewicz et al. · Cell Open access Apr 2015 861
41 Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease Lauren E. Tebay, Holly A. Robertson, Stephen T. Durant et al. · Free Radical Biology and Medicine Open access 30 Jun 2015 838
42 Targeting cardiac fibrosis with engineered T cells Haig K. Aghajanian et al. · Nature Open access 11 Sep 2019 831
43 An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans Robert A. Scott et al. · Diabetes Open access175 authors 31 May 2017 830
44 Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis Marijana Vujković et al. · Nature Genetics Open access182 authors 15 Jun 2020 822
45 Comprehensive mapping of immune perturbations associated with severe COVID-19 Leticia Kuri-Cervantes et al. · Science Immunology Open access 3 Jul 2020 808
46 Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study Marina Cuchel, Emma Anne Meagher, Hendrik du Toit Theron et al. · The Lancet Open access 2 Nov 2012 751
47 Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination Rishi R. Goel et al. · Science Immunology Open access 2 Apr 2021 739
48 TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision Zeyu Chen et al. · Immunity Open access 9 Oct 2019 736
49 A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma Alexander Chan Chi Huang et al. · Nature Medicine Open access 25 Feb 2019 715
50 Harmonics of Circadian Gene Transcription in Mammals Michael E. Hughes, Luciano DiTacchio, Kevin R. Hayes et al. · PLoS Genetics Open access 2 Apr 2009 708

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.